Association Between Number of Actionable Pharmacogenetic Variants and Length of Hospital Stay

被引：1

作者：

Finkelstein, Joseph ^{[1
]}

Zhang, Frederick ^{[2
]}

Cabrera, Manuel ^{[2
]}

机构：

[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[2] Columbia Univ, Irving Med Ctr, New York, NY 10027 USA

来源：

IMPORTANCE OF HEALTH INFORMATICS IN PUBLIC HEALTH DURING A PANDEMIC | 2020年 / 272卷

关键词：

Pharmacogenetics; allelic variation; hospitalization; electronic health record; OLDER-ADULTS; POLYPHARMACY; CARE;

D O I：

10.3233/SHTI200527

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

The goal of this study was to evaluate association between number of pharmacogenetic variants and length of hospital stay. Electronic medical records were combined with exome sequencing results in 450 hospitalized patients. Deidentified data set was used to characterize urgent care utilization and to identify presence of 44 actionable pharmacogenetic variants according to the guidelines of the Clinical Pharmacogenetics Implementation Consortium. The average age was 58.03 +/- 16.47 ranging from 20 to 91 years old, average number of pharmacogenetic variants was 61.22 +/- 26.52 ranging from 20 to 169, and mean length of hospital stay was 6.50 +/- 4.29 ranging between 1 and 42 days. After adjusting for patient socio-demographics and overall disease severity reflected by the Charlson comorbidity index, a significant association between mean length of stay and number of pharmacogenetic variants was found using generalized linear regression (p-value < 2.2e-16).

引用

收藏

页码：195 / 198

页数：4

相关论文

共 10 条

[1] Evaluating empirical bounds on complex disease genetic architecture [J].

Agarwala, Vineeta ;

Flannick, Jason ;

Sunyaev, Shamil ;

Altshuler, David .

NATURE GENETICS, 2013, 45 (12) :1418-U167

[2]

Cabrera Manuel, 2016, AMIA Jt Summits Transl Sci Proc, V2016, P16

[3] Genetic predisposition to adverse drug reactions in the intensive care unit [J].

Empey, Philip E. .

CRITICAL CARE MEDICINE, 2010, 38 :S106-S116

[4] Pharmacogenetic polymorphism as an independent risk factor for frequent hospitalizations in older adults with polypharmacy: a pilot study [J].

Finkelstein, Joseph ;

Friedman, Carol ;

Hripcsak, George ;

Cabrera, Manuel .

PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2016, 9 :107-116

[5] Potential utility of precision medicine for older adults with polypharmacy: a case series study [J].

Finkelstein, Joseph ;

Friedman, Carol ;

Hripcsak, George ;

Cabrera, Manuel .

PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2016, 9 :31-45

[6] The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future [J].

Gottesman, Omri ;

Kuivaniemi, Helena ;

Tromp, Gerard ;

Faucett, W. Andrew ;

Li, Rongling ;

Manolio, Teri A. ;

Sanderson, Saskia C. ;

Kannry, Joseph ;

Zinberg, Randi ;

Basford, Melissa A. ;

Brilliant, Murray ;

Carey, David J. ;

Chisholm, Rex L. ;

Chute, Christopher G. ;

Connolly, John J. ;

Crosslin, David ;

Denny, Joshua C. ;

Gallego, Carlos J. ;

Haines, Jonathan L. ;

Hakonarson, Hakon ;

Harley, John ;

Jarvik, Gail P. ;

Kohane, Isaac ;

Kullo, Iftikhar J. ;

Larson, Eric B. ;

McCarty, Catherine ;

Ritchie, Marylyn D. ;

Roden, Dan M. ;

Smith, Maureen E. ;

Bottinger, Erwin P. ;

Williams, Marc S. .

GENETICS IN MEDICINE, 2013, 15 (10) :761-771

[7] Role of pharmacogenetics in public health and clinical health care: a SWOT analysis [J].

Kapoor, Ritika ;

Tan-Koi, Wei Chuen ;

Teo, Yik-Ying .

EUROPEAN JOURNAL OF HUMAN GENETICS, 2016, 24 (12) :1651-1657

[8] Finding the missing heritability of complex diseases [J].

Manolio, Teri A. ;

Collins, Francis S. ;

Cox, Nancy J. ;

Goldstein, David B. ;

Hindorff, Lucia A. ;

Hunter, David J. ;

McCarthy, Mark I. ;

Ramos, Erin M. ;

Cardon, Lon R. ;

Chakravarti, Aravinda ;

Cho, Judy H. ;

Guttmacher, Alan E. ;

Kong, Augustine ;

Kruglyak, Leonid ;

Mardis, Elaine ;

Rotimi, Charles N. ;

Slatkin, Montgomery ;

Valle, David ;

Whittemore, Alice S. ;

Boehnke, Michael ;

Clark, Andrew G. ;

Eichler, Evan E. ;

Gibson, Greg ;

Haines, Jonathan L. ;

Mackay, Trudy F. C. ;

McCarroll, Steven A. ;

Visscher, Peter M. .

NATURE, 2009, 461 (7265) :747-753

[9] The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later [J].

Relling, Mary V. ;

Klein, Teri E. ;

Gammal, Roseann S. ;

Whirl-Carrillo, Michelle ;

Hoffman, James M. ;

Caudle, Kelly E. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (01) :171-175

[10] Inconsistency in race and ethnic classification in pharmacogenetics studies and its potential clinical implications [J].

Zhang, Frederick ;

Finkelstein, Joseph .

PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2019, 12 :107-123